{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:55:06Z","timestamp":1772150106662,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.autrev.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T13:06:59Z","timestamp":1416316019000},"page":"210-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early\/early SSc or pre-SSc)"],"prefix":"10.1016","volume":"14","author":[{"given":"Gabriele","family":"Valentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.11.002_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nrrheum.2014.6","article-title":"Pathogenesis and prevention of rheumatic disease","volume":"10","author":"Deane","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.1780270201","article-title":"A long-term longitudinal study of anticentromere antibodies","volume":"27","author":"Tramposch","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2013.12.001","article-title":"Raynaud's phenomenon: from molecular pathogenesis to therapy","volume":"13","author":"Prete","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.002_bb0020","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/ard.2008.106302","article-title":"The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop prevention or rescue strategy","volume":"68","author":"Matucci Cerinic","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.002_bb0030","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi consensus study from EULAR Scleroderma Trials and Research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.002_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/rheumatology\/keq176","article-title":"Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features","volume":"50","author":"Valentini","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.11.002_bb0040","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1186\/ar4019","article-title":"Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement","volume":"14","author":"Valentini","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.002_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/annrheumdis-2012-202295","article-title":"Very early versus early disease: the evolving definition of the \u2018many faces\u2019 of systemic sclerosis","volume":"72","author":"Matucci-Cerinic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.002_bb0050","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4236","article-title":"Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers","volume":"15","author":"Valentini","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.002_bb0055","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.002_bb0060","article-title":"Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS\/EUSTAR centre","author":"Lepri","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.002_bb0065","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/acr.22304","article-title":"Early systemic sclerosis: analysis of the disease course in patients with marker autoantibodies or capillaroscopic positivity or both","volume":"66","author":"Valentini","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2014.11.002_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","article-title":"Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels","volume":"34","author":"Vettori","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1573397110666140404001756","article-title":"The concept of early systemic sclerosis following 2013 ACR\\EULAR Criteria for the Classification of Systemic Sclerosis","volume":"10","author":"Valentini","year":"2014","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.autrev.2014.11.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keu381","article-title":"Role of class II human leukocyte antigens in the progression from early to definite systemic sclerosis","author":"Vigone","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.11.002_bb0085","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.autrev.2012.11.006","article-title":"The role of nail-videocapillaroscopy in early diagnosis of scleroderma","volume":"12","author":"Rossi","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.002_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2012.07.005","article-title":"Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis","volume":"12","author":"Villalta","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.002_bb0265","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.002_bb0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for classification of systemic sclerosis (scleroderma)","volume":"23","author":"Subcommittee Criteria of the AmericanRheumatism Association Diagnostic and TherapeuticCriteria Committee","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0115","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification Criteria for Systemic Sclerosis: an ACR-EULAR collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0120","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0125","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G","article-title":"Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients","volume":"43","author":"Poormoghin","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0130","series-title":"Personal communication","author":"Pope","year":"2014"},{"key":"10.1016\/j.autrev.2014.11.002_bb0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.autrev.2010.09.013","article-title":"Undifferentiated Connective Tissue Diseases (UCTD): simplified systemic autoimmune diseases","volume":"10","author":"Mosca","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.002_bb0140","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3899\/jrheum.101243","article-title":"PHAROS Investigators. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population","volume":"38","author":"Hinchcliff","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study","volume":"44","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-0172(75)90017-7","article-title":"Pathogenesis of systemic sclerosis: a vascular hypothesis","volume":"4","author":"Campbell","year":"1975","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0155","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.11.002_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.002_bb0165","series-title":"Lung function testing","first-page":"127","article-title":"Transfer factor for carbon monoxide","volume":"10","author":"Hortstman","year":"2005"},{"key":"10.1016\/j.autrev.2014.11.002_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9343(84)90783-6","article-title":"Raynaud's phenomenon of the lung","volume":"76","author":"Fahey","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2014.11.002_bb0175","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","article-title":"Gastrointestinal motility disorders in scleroderma","volume":"37","author":"Sjogren","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0180","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0002-8703(87)90795-2","article-title":"Evaluation of left ventricular diastolic dysfunction: clinical relevance and recent Doppler echocardiographic insights","volume":"114","author":"Labovitz","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2014.11.002_bb0185","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/rheumatology\/27.6.426","article-title":"Decreased esophageal blood flow in patients with Raynaud's phenomenon","volume":"27","author":"Belch","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00392-006-0384-9","article-title":"Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenon","volume":"95","author":"Tsch\u00f6pe","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.atherosclerosis.2008.06.021","article-title":"Vascular reactivity in patients with Undifferentiated Connective Tissue Diseases","volume":"203","author":"Mosca","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2014.11.002_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000247759","article-title":"Raynaud's phenomenon with digital necrosis as the first manifestations of undifferentiated connective tissue syndrome","volume":"182","author":"Saban","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/j.autrev.2014.11.002_bb0205","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/ard.54.12.944","article-title":"Early rheumatoid arthritis: time to aim for remission?","volume":"54","author":"Emery","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.002_bb0210","series-title":"Systemic sclerosis","first-page":"17","article-title":"Classification, prognosis","author":"Medsger","year":"2004"},{"key":"10.1016\/j.autrev.2014.11.002_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03009742.2012.736532","article-title":"Increased serum type I interferon activity in early systemic sclerosis is associated with antibodies against Sj\u00f6gren's syndrome antigens and nuclear ribonucleoprotein antigens","volume":"42","author":"Wuttge","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"Suppl. 4","key":"10.1016\/j.autrev.2014.11.002_bb0220","first-page":"S51 A","article-title":"Systemic sclerosis without Raynaud's phenomenon","volume":"29","author":"Young","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.002_bb0225","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.002_bb0230","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1586\/1744666X.2013.848792","article-title":"Current status of systemic sclerosis biomarkers: application for diagnosis, management and drug development","volume":"9","author":"Castelino","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0235","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/BOR.0b013e3283588dcf","article-title":"Renal disease in scleroderma: an update on evaluation, risk stratification and management","volume":"24","author":"Shanmugam","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0240","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1378\/chest.12-2396","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"144","author":"Chaisson","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.11.002_bb0245","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acr.22018","article-title":"Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis","volume":"65","author":"Tingley","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2014.11.002_bb0250","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.12-0741","article-title":"Diagnosis and treatment of connective tissue disease-associated interstitial lung disease","volume":"143","author":"Vij","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.11.002_bb0255","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.bor.0000434669.32150.ac","article-title":"Stem cell transplantation in systemic sclerosis","volume":"25","author":"van Laar","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.002_bb0260","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/annrheumdis-2013-204221","article-title":"Combined inhibition of morphogen pathways demonstrates additive antifibrotic effect and improved tolerability","volume":"73","author":"Distler","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T17:54:53Z","timestamp":1538070893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1568997214002602"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.11.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early\/early SSc or pre-SSc)","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}